On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions

被引:8
作者
Gascon, Fernando
de la Fuente, David
Puente, Javier
Lozano, Jesus
机构
[1] Univ Oviedo, Escuela Politecn Super Ingn Gijon, Business Adm & Accounting Dept, Gijon 33204, Asturias, Spain
[2] Univ Oviedo, Fac Econ, Business Adm & Accounting Dept, E-33006 Oviedo, Spain
关键词
pharmaceutical generics; aggregate demand and supply; fuzzy decision-making systems; forecasting consumption and production; uncertainty;
D O I
10.1016/j.artmed.2007.07.001
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Objective: The aim of this paper is to develop a methodology that is useful for analyzing, from a macroeconomic perspective, the aggregate demand and the aggregate supply features of the market of pharmaceutical generics. In order to determine the potential consumption and the potential production of pharmaceutical generics in different countries, two fuzzy decision support systems are proposed. Methods and materials: Two fuzzy decision support systems, both based on the Mamdani model, were applied in this paper. These systems, generated by Matlab Toolbox 'Fuzzy' (v. 2.0), are able to determine the potential of a country for the manufacturing or the consumption of pharmaceutical generics. The systems make use of three macroeconomic input variables. Results: In an empirical application of our proposed methodology, the potential towards consumption and manufacturing in Holland, Sweden, Italy and Spain has been estimated from national indicators. Cross-country comparisons are made and graphical surfaces are analyzed in order to interpret the results. Conclusions: The main contribution of this work is the development of a methodology that is useful for analyzing aggregate demand and aggregate supply characteristics of pharmaceutical generics. The methodology is valid for carrying out a systematic analysis of the potential generics have at a macrolevel in different countries. The main advantages of the use of fuzzy decision support systems in the context of pharmaceutical generics are the flexibility in the construction of the system, the speed in interpreting the results offered by the inference and surface maps and the ease with which a sensitivity analysis of the potential behavior of a given country may be performed. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 235
页数:13
相关论文
共 34 条
  • [1] Deregulating the pharmacy market: the case of Iceland and Norway
    Anell, A
    [J]. HEALTH POLICY, 2005, 75 (01) : 9 - 17
  • [2] An efficient approach to solving fuzzy MADM problems
    Chen, CB
    Klein, CM
    [J]. FUZZY SETS AND SYSTEMS, 1997, 88 (01) : 51 - 67
  • [3] Pharmaceutical reference prices - How do they work in practice?
    Dickson, M
    Redwood, H
    [J]. PHARMACOECONOMICS, 1998, 14 (05) : 471 - 479
  • [4] Driankov D, 1996, INTRO FUZZY CONTROL
  • [5] ELFEKI S, 2005, EC SURVEY PHARM
  • [6] European healthcare policies for controlling drug expenditure
    Ess, SM
    Schneeweiss, S
    Szucs, TD
    [J]. PHARMACOECONOMICS, 2003, 21 (02) : 89 - 103
  • [7] A comparative analysis of generics markets in five European countries
    Garattini, L
    Tediosi, F
    [J]. HEALTH POLICY, 2000, 51 (03) : 149 - 162
  • [8] A COMPARATIVE-ANALYSIS OF THE PHARMACEUTICAL MARKET IN 4 EUROPEAN COUNTRIES
    GARATTINI, L
    SALVIONI, F
    SCOPELLITI, D
    GARATTINI, S
    [J]. PHARMACOECONOMICS, 1994, 6 (05) : 417 - 423
  • [9] The drug market in four European countries
    Garattini, S
    [J]. PHARMACOECONOMICS, 1998, 14 (Suppl 1) : 69 - 79
  • [10] JACOBZONE S, 2000, OECD LABOUR MARKET S, P40